<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>JCAD &#187; Pyoderma Gangrenosum</title>
	<atom:link href="http://www.jcadonline.com/category/areas-of-interest/pyoderma-gangrenosum/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.jcadonline.com</link>
	<description>The Journal of Clinical and Aesthetic Dermatology (JCAD)</description>
	<lastBuildDate>Thu, 19 Jan 2012 16:38:25 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>A Second Case of Sunitinib-associated Pyoderma Gangrenosum</title>
		<link>http://www.jcadonline.com/a-second-case-of-sunitinib-associated-pyoderma-gangrenosum/</link>
		<comments>http://www.jcadonline.com/a-second-case-of-sunitinib-associated-pyoderma-gangrenosum/#comments</comments>
		<pubDate>Thu, 05 Aug 2010 17:40:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[08-2010 (August 2010)]]></category>
		<category><![CDATA[Case Report]]></category>
		<category><![CDATA[Pyoderma Gangrenosum]]></category>
		<category><![CDATA["a second case of sunitinib-associated pyoderma "]]></category>
		<category><![CDATA[cache:msa326dpb-yj:www.jcadonline.com/aesthetic-update-what’s-new-in-fillers-in-2010/ "prevelle lift" information mentor]]></category>
		<category><![CDATA[correlation between radiation and development of pyoderma gangrenosum]]></category>
		<category><![CDATA[deep pyoderma]]></category>
		<category><![CDATA[epidermoid cyste sunitinib]]></category>
		<category><![CDATA[gist and pyoderma]]></category>
		<category><![CDATA[gist cancer and pyoderma]]></category>
		<category><![CDATA[granuloma]]></category>
		<category><![CDATA[images of pyoderma gangrenosum]]></category>
		<category><![CDATA[impetigo]]></category>
		<category><![CDATA[inverser le diabète imatinib sunitinib]]></category>
		<category><![CDATA[lympho-proliferative disorder]]></category>
		<category><![CDATA[minocycline side effects]]></category>
		<category><![CDATA[necrotic arachnidism]]></category>
		<category><![CDATA[necrotic base]]></category>
		<category><![CDATA[nekrosis gangrenosa]]></category>
		<category><![CDATA[pathergic threshold]]></category>
		<category><![CDATA[pics of lower extremity ulceration]]></category>
		<category><![CDATA[pioderma gangrenoso]]></category>
		<category><![CDATA[primary pyoderma gangrenosum]]></category>
		<category><![CDATA[ptu-positive pyoderma gangrenosum]]></category>
		<category><![CDATA[pyoderma]]></category>
		<category><![CDATA[pyoderma gangrenosum and interferon 2a/b]]></category>
		<category><![CDATA[pyoderma gangrenosum drug induced]]></category>
		<category><![CDATA[pyoderma gangrenosum facial surgery]]></category>
		<category><![CDATA[pyoderma gangrenosum growth factors]]></category>
		<category><![CDATA[pyoderma gangrenosum lactic acid]]></category>
		<category><![CDATA[pyoderma gangrenosum latic acid in blood stream]]></category>
		<category><![CDATA[pyoderma gangrenosum pictures]]></category>
		<category><![CDATA[pyoderma gangrenosum treatment - ohio]]></category>
		<category><![CDATA[pyoderma gangrenosum triggered by hair removal]]></category>
		<category><![CDATA[pyoderma gangrenosum with the use of sunitinib]]></category>
		<category><![CDATA[pyoderma gangresosum]]></category>
		<category><![CDATA[pyoderma sorafenib]]></category>
		<category><![CDATA[pyoderma vegf]]></category>
		<category><![CDATA[pyoderma with ulcers]]></category>
		<category><![CDATA[pyogenic gangrenosum and unna boots]]></category>
		<category><![CDATA[pyroderma and apligraf]]></category>
		<category><![CDATA[pyroderma gangrenosum, pictures]]></category>
		<category><![CDATA[side effects of pyoderma gangrenosum]]></category>
		<category><![CDATA[silicone pyoderma gangrenosum]]></category>
		<category><![CDATA[sorafenib pyoderma]]></category>
		<category><![CDATA[sunitinib and pyoderma gangrenosum]]></category>
		<category><![CDATA[sunitinib capillary depigmentation]]></category>
		<category><![CDATA[sunitinib comment]]></category>
		<category><![CDATA[sunitinib cutaneous toxicity]]></category>
		<category><![CDATA[sunitinib facial erythema]]></category>
		<category><![CDATA[sunitinib gist case report treatment]]></category>
		<category><![CDATA[sunitinib in actinic keratosis]]></category>
		<category><![CDATA[sunitinib in treatment of actinic keratosis]]></category>
		<category><![CDATA[sunitinib reactions skin]]></category>
		<category><![CDATA[unna boot image]]></category>
		<category><![CDATA[wells syndrome repetitive pustules]]></category>
		<category><![CDATA[what are side effects of pyroderma gangrenosum?]]></category>
		<category><![CDATA[what are the side effects of pyodermagangrenosum]]></category>

		<guid isPermaLink="false">http://www.jcadonline.com/?p=2713</guid>
		<description><![CDATA[Steven M. Dean, DO, FACP, RPVI; Matthew Zirwas, MD The Ohio State University, Columbus, Ohio Disclosure: Drs. Dean and Zirwas report no relevant conflicts of interest. Abstract Pyoderma gangrenosum is a painful, noninfectious, ulcerative, cutaneous disorder that most commonly affects the lower extremities. The diagnosis is made by recognizing the characteristic clinical manifestations in the [...]]]></description>
		<wfw:commentRss>http://www.jcadonline.com/a-second-case-of-sunitinib-associated-pyoderma-gangrenosum/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

